Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Varicella-zoster virus susceptibility and primary healthcare consultations in Norway

Fig. 2

Age-specific varicella-zoster virus seropositivity (serum IgG antibodies) and age-specific consultation rate (cases per 100,000 population) of varicella and herpes zoster as first encounter with primary healthcare in Norway 2008–2012. The blue line represents percent of VZV seropositive individuals as measured by serum IgG antibodies in a subset of Norwegian population (n = 2013). Orange line shows the number of varicella cases per 100,000 population measured as first encounter with primary healthcare in Norway, 2008–2012 (n = 56,126). The pink line represents number of herpes zoster cases per 100,000 population, measured as first encounter with primary healthcare in Norway, 2008–2012 (KUHR)

Back to article page